Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Davies, S. R. Davies, A. L. Higgins, J. P. T. Caldwell, D. M. Thornton, Z. A. Aiton, E. Ali, I. Dawson, S. McGrath, C. Parkhouse, T. Yardley, L. Yates, J. Letley, L. Ismail, S. A. French, C. E.

Recipient-focused interventions to increase vaccine uptake in high and upper-middle income countries: a systematic review and network meta-analysis

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Askar, M. Ali, K. A. Batke, M. Brugger, T. Falman, A. Robertson, A. H. Perez, J. J. Johansen, K. de Jonge, J. Krause, T. G. Kulper-Schiek, W. Meerpohl, J. J. Melidou, A. Nohynek, H. Olmedo, C. Olsson, K. Pavlopoulou, I. Piechotta, V. Rubin, J. Schlaberg, J. Schmucker, C. Siemens, W. Stratil, J. Ucakar, V. Wichmann, O. Harder, T.

Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Guo, Y. Liu, X. Nicholas, S. Maitland, E. Liu, R.

Revisiting Global HPV Vaccination Behavior and Its Determinants: A Comprehensive Review

  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Kolsuz, S. Gullu, D. Karahan, K. D. Ergonul, O.

Risk factors and preventive role of vaccination in adult tetanus fatality: a systematic review of reported cases (1990-2024) and meta-analysis

  • Adults
  • Older adults
  • Tetanus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ugwu, C. L. J. Bragazzi, N. L. Wu, J. Kong, J. D. Asgary, A. Orbinski, J. Woldegerima, W. A.

Risk factors associated with human Mpox infection: A systematic review and meta-Analysis

  • All age groups
  • Mpox
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Kosmeri, C. Klapas, A. Evripidou, N. Kantza, E. Serbis, A. Siomou, E. Ladomenou, F.

Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis

  • Children
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Tahrat, H. Munir, A. Marchetti, F.

Rotavirus vaccine coverage, completion, and compliance: A systematic literature review

  • Newborn
  • Children
  • Rotavirus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Vidya, A. P. Wijaya, N. J. Gathmir, D. Z. P. Kornel, N. A. K. Farhan, M. Sianipar, I. R.

Safety and efficacy of high-dose versus standard-dose influenza vaccines in hematopoietic stem cell transplant recipients: A meta-analysis of randomized controlled trials

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Farag, A. Elkholy, M. K. A. Genidy, A. M. Eltobgy, A.

Safety and efficacy of maternal RSV vaccination: a systematic review and meta-analysis

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Xiao, Q. Yang, R. Zhang, L. Tian, Y. Wang, X. Li, W.

Safety and Efficacy of Respiratory Syncytial Virus Vaccination in Older Adults: Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Adults
  • Older adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...